<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN"
"http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" lang="en" xml:lang="en">
<head>
<!-- 2017-06-24 Sat 10:28 -->
<meta http-equiv="Content-Type" content="text/html;charset=utf-8" />
<meta name="viewport" content="width=device-width, initial-scale=1" />
<title>Clinical Trial Design With Stress Test</title>
<meta name="generator" content="Org mode" />
<style type="text/css">
 <!--/*--><![CDATA[/*><!--*/
  .title  { text-align: center;
             margin-bottom: .2em; }
  .subtitle { text-align: center;
              font-size: medium;
              font-weight: bold;
              margin-top:0; }
  .todo   { font-family: monospace; color: red; }
  .done   { font-family: monospace; color: green; }
  .priority { font-family: monospace; color: orange; }
  .tag    { background-color: #eee; font-family: monospace;
            padding: 2px; font-size: 80%; font-weight: normal; }
  .timestamp { color: #bebebe; }
  .timestamp-kwd { color: #5f9ea0; }
  .org-right  { margin-left: auto; margin-right: 0px;  text-align: right; }
  .org-left   { margin-left: 0px;  margin-right: auto; text-align: left; }
  .org-center { margin-left: auto; margin-right: auto; text-align: center; }
  .underline { text-decoration: underline; }
  #postamble p, #preamble p { font-size: 90%; margin: .2em; }
  p.verse { margin-left: 3%; }
  pre {
    border: 1px solid #ccc;
    box-shadow: 3px 3px 3px #eee;
    padding: 8pt;
    font-family: monospace;
    overflow: auto;
    margin: 1.2em;
  }
  pre.src {
    position: relative;
    overflow: visible;
    padding-top: 1.2em;
  }
  pre.src:before {
    display: none;
    position: absolute;
    background-color: white;
    top: -10px;
    right: 10px;
    padding: 3px;
    border: 1px solid black;
  }
  pre.src:hover:before { display: inline;}
  /* Languages per Org manual */
  pre.src-asymptote:before { content: 'Asymptote'; }
  pre.src-awk:before { content: 'Awk'; }
  pre.src-C:before { content: 'C'; }
  /* pre.src-C++ doesn't work in CSS */
  pre.src-clojure:before { content: 'Clojure'; }
  pre.src-css:before { content: 'CSS'; }
  pre.src-D:before { content: 'D'; }
  pre.src-ditaa:before { content: 'ditaa'; }
  pre.src-dot:before { content: 'Graphviz'; }
  pre.src-calc:before { content: 'Emacs Calc'; }
  pre.src-emacs-lisp:before { content: 'Emacs Lisp'; }
  pre.src-fortran:before { content: 'Fortran'; }
  pre.src-gnuplot:before { content: 'gnuplot'; }
  pre.src-haskell:before { content: 'Haskell'; }
  pre.src-java:before { content: 'Java'; }
  pre.src-js:before { content: 'Javascript'; }
  pre.src-latex:before { content: 'LaTeX'; }
  pre.src-ledger:before { content: 'Ledger'; }
  pre.src-lisp:before { content: 'Lisp'; }
  pre.src-lilypond:before { content: 'Lilypond'; }
  pre.src-lua:before { content: 'Lua'; }
  pre.src-matlab:before { content: 'MATLAB'; }
  pre.src-mscgen:before { content: 'Mscgen'; }
  pre.src-ocaml:before { content: 'Objective Caml'; }
  pre.src-octave:before { content: 'Octave'; }
  pre.src-org:before { content: 'Org mode'; }
  pre.src-oz:before { content: 'OZ'; }
  pre.src-plantuml:before { content: 'Plantuml'; }
  pre.src-processing:before { content: 'Processing.js'; }
  pre.src-python:before { content: 'Python'; }
  pre.src-R:before { content: 'R'; }
  pre.src-ruby:before { content: 'Ruby'; }
  pre.src-sass:before { content: 'Sass'; }
  pre.src-scheme:before { content: 'Scheme'; }
  pre.src-screen:before { content: 'Gnu Screen'; }
  pre.src-sed:before { content: 'Sed'; }
  pre.src-sh:before { content: 'shell'; }
  pre.src-sql:before { content: 'SQL'; }
  pre.src-sqlite:before { content: 'SQLite'; }
  /* additional languages in org.el's org-babel-load-languages alist */
  pre.src-forth:before { content: 'Forth'; }
  pre.src-io:before { content: 'IO'; }
  pre.src-J:before { content: 'J'; }
  pre.src-makefile:before { content: 'Makefile'; }
  pre.src-maxima:before { content: 'Maxima'; }
  pre.src-perl:before { content: 'Perl'; }
  pre.src-picolisp:before { content: 'Pico Lisp'; }
  pre.src-scala:before { content: 'Scala'; }
  pre.src-shell:before { content: 'Shell Script'; }
  pre.src-ebnf2ps:before { content: 'ebfn2ps'; }
  /* additional language identifiers per "defun org-babel-execute"
       in ob-*.el */
  pre.src-cpp:before  { content: 'C++'; }
  pre.src-abc:before  { content: 'ABC'; }
  pre.src-coq:before  { content: 'Coq'; }
  pre.src-groovy:before  { content: 'Groovy'; }
  /* additional language identifiers from org-babel-shell-names in
     ob-shell.el: ob-shell is the only babel language using a lambda to put
     the execution function name together. */
  pre.src-bash:before  { content: 'bash'; }
  pre.src-csh:before  { content: 'csh'; }
  pre.src-ash:before  { content: 'ash'; }
  pre.src-dash:before  { content: 'dash'; }
  pre.src-ksh:before  { content: 'ksh'; }
  pre.src-mksh:before  { content: 'mksh'; }
  pre.src-posh:before  { content: 'posh'; }
  /* Additional Emacs modes also supported by the LaTeX listings package */
  pre.src-ada:before { content: 'Ada'; }
  pre.src-asm:before { content: 'Assembler'; }
  pre.src-caml:before { content: 'Caml'; }
  pre.src-delphi:before { content: 'Delphi'; }
  pre.src-html:before { content: 'HTML'; }
  pre.src-idl:before { content: 'IDL'; }
  pre.src-mercury:before { content: 'Mercury'; }
  pre.src-metapost:before { content: 'MetaPost'; }
  pre.src-modula-2:before { content: 'Modula-2'; }
  pre.src-pascal:before { content: 'Pascal'; }
  pre.src-ps:before { content: 'PostScript'; }
  pre.src-prolog:before { content: 'Prolog'; }
  pre.src-simula:before { content: 'Simula'; }
  pre.src-tcl:before { content: 'tcl'; }
  pre.src-tex:before { content: 'TeX'; }
  pre.src-plain-tex:before { content: 'Plain TeX'; }
  pre.src-verilog:before { content: 'Verilog'; }
  pre.src-vhdl:before { content: 'VHDL'; }
  pre.src-xml:before { content: 'XML'; }
  pre.src-nxml:before { content: 'XML'; }
  /* add a generic configuration mode; LaTeX export needs an additional
     (add-to-list 'org-latex-listings-langs '(conf " ")) in .emacs */
  pre.src-conf:before { content: 'Configuration File'; }

  table { border-collapse:collapse; }
  caption.t-above { caption-side: top; }
  caption.t-bottom { caption-side: bottom; }
  td, th { vertical-align:top;  }
  th.org-right  { text-align: center;  }
  th.org-left   { text-align: center;   }
  th.org-center { text-align: center; }
  td.org-right  { text-align: right;  }
  td.org-left   { text-align: left;   }
  td.org-center { text-align: center; }
  dt { font-weight: bold; }
  .footpara { display: inline; }
  .footdef  { margin-bottom: 1em; }
  .figure { padding: 1em; }
  .figure p { text-align: center; }
  .inlinetask {
    padding: 10px;
    border: 2px solid gray;
    margin: 10px;
    background: #ffffcc;
  }
  #org-div-home-and-up
   { text-align: right; font-size: 70%; white-space: nowrap; }
  textarea { overflow-x: auto; }
  .linenr { font-size: smaller }
  .code-highlighted { background-color: #ffff00; }
  .org-info-js_info-navigation { border-style: none; }
  #org-info-js_console-label
    { font-size: 10px; font-weight: bold; white-space: nowrap; }
  .org-info-js_search-highlight
    { background-color: #ffff00; color: #000000; font-weight: bold; }
  .org-svg { width: 90%; }
  /*]]>*/-->
</style>
<script type="text/javascript">
/*
@licstart  The following is the entire license notice for the
JavaScript code in this tag.

Copyright (C) 2012-2017 Free Software Foundation, Inc.

The JavaScript code in this tag is free software: you can
redistribute it and/or modify it under the terms of the GNU
General Public License (GNU GPL) as published by the Free Software
Foundation, either version 3 of the License, or (at your option)
any later version.  The code is distributed WITHOUT ANY WARRANTY;
without even the implied warranty of MERCHANTABILITY or FITNESS
FOR A PARTICULAR PURPOSE.  See the GNU GPL for more details.

As additional permission under GNU GPL version 3 section 7, you
may distribute non-source (e.g., minimized or compacted) forms of
that code without the copy of the GNU GPL normally required by
section 4, provided you include this license notice and a URL
through which recipients can access the Corresponding Source.


@licend  The above is the entire license notice
for the JavaScript code in this tag.
*/
<!--/*--><![CDATA[/*><!--*/
 function CodeHighlightOn(elem, id)
 {
   var target = document.getElementById(id);
   if(null != target) {
     elem.cacheClassElem = elem.className;
     elem.cacheClassTarget = target.className;
     target.className = "code-highlighted";
     elem.className   = "code-highlighted";
   }
 }
 function CodeHighlightOff(elem, id)
 {
   var target = document.getElementById(id);
   if(elem.cacheClassElem)
     elem.className = elem.cacheClassElem;
   if(elem.cacheClassTarget)
     target.className = elem.cacheClassTarget;
 }
/*]]>*///-->
</script>
<script type="text/x-mathjax-config">
    MathJax.Hub.Config({
        displayAlign: "center",
        displayIndent: "0em",

        "HTML-CSS": { scale: 100,
                        linebreaks: { automatic: "false" },
                        webFont: "TeX"
                       },
        SVG: {scale: 100,
              linebreaks: { automatic: "false" },
              font: "TeX"},
        NativeMML: {scale: 100},
        TeX: { equationNumbers: {autoNumber: "AMS"},
               MultLineWidth: "85%",
               TagSide: "right",
               TagIndent: ".8em"
             }
});
</script>
<script type="text/javascript"
        src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.0/MathJax.js?config=TeX-AMS_HTML"></script>
</head>
<body>
<div id="content">
<h1 class="title">Clinical Trial Design With Stress Test</h1>

<div id="outline-container-org65e2fd5" class="outline-2">
<h2 id="org65e2fd5"><span class="section-number-2">1</span> Introduction</h2>
<div class="outline-text-2" id="text-1">
</div><div id="outline-container-org0f70d1d" class="outline-3">
<h3 id="org0f70d1d"><span class="section-number-3">1.1</span> Notation</h3>
<div class="outline-text-3" id="text-1-1">
<p>
Consider a randomized Phase II clinical study that evaluates the efficacy of
some medical intervention.
</p>

<p>
We confine our discussion to the cases where the overall intent-to-treat
population \(S_C\) consists of two subgroups, \(S_1\) and \(S_2\), that are
distinguished by the status of a <i>binary</i> biomarker.
</p>

<p>
Let \(j=1,2,C\) be a group index respectively denoting \(S_1\), \(S_2\) and the
overall population \(S_C\). For each subject, we observe outcome \(Y_i\), treatment
assignment \(T_i\) (\(T_i=0\) for control and \(1\) for treatment), and subgroup
indicator (i.e. biomarker status) \(A_i\) (\(A_i=1,2\)). For notation convenience,
we assume \(A_i = C\) holds for all \(i\).
</p>

<p>
Denote \(\delta_j\) the treatment effect size in group \(j\). That is, \[\delta_j =
   E(Y_i|T_i=1, A_i=j) - E(Y_i|T_i=0, A_i=j).\] Denote \(\pi_j = P(A_i =j)\) as the
proportion of group \(j\) in the overall population (\(\pi_C=1\)). Then, \(\delta_C =
   \pi_1 \delta_1 + \pi_2 \delta_2\). Without loss of generality, we assume that the
treatment effect is stronger in subgroup \(S_1\) than in \(S_2\); that is,
\(\delta_1>\delta_2\) and consequently, \(\delta_1 > \delta_C\).
</p>

<p>
The goal is to evaluate if the treatment is effective for the subgroups \(S_1\)
and \(S_2\) and for the overall population. Hence, there are three hypotheses of
interest: \[H_{0,j}: \delta_j = 0 \quad for \quad j=1,2,C.\]
</p>
</div>
</div>
<div id="outline-container-org1e1ca85" class="outline-3">
<h3 id="org1e1ca85"><span class="section-number-3">1.2</span> Study Design</h3>
<div class="outline-text-3" id="text-1-2">
<p>
Given the data generating distributions \(\scr{F}\), a <i>valid</i> study design
\(\scr{D}\) is defined as a set of actions \(\scr{A}\) that satisfy certain
constraints \(\scr{C}\). That is, \[\scr{D} = \{ \scr{A}; \scr{C}, \scr{F}\}.\]
</p>

<p>
The data generating distribution \(\scr{F}\) is a realization of the
assumptions about how the data on the study are distributed. Data here often
refer to the actual outcomes (i.e. \(Y_i\)) or its sufficient statistics (e.g.
treatment effect \(\delta_j\)). In general, \(\scr{F}\) includes the probability
assumptions for all the data that may occur on the study. These include
baseline covariates, missingness, enrollment rate, subpopulation proportions
etc.. The actions \(\scr{A}\) distinguish different designs. For example, the
determination of sample size, number of interim analyses or stages, test
statistics, efficacy and futility boundaries are all actions that a specific
design needs to consider. The constraints \(\scr{C}\) are often defined with
respect to the type I and type II error.
</p>

<p>
Give a loss function \(L\) (e.g. average sample size, mean squared error), the
<i>optimal</i> design \(\scr{D}^*\) given \(\scr{F}\) and \(\scr{C}\) is the <i>valid</i>
design that minimizes the loss. That is, \[ \scr{D}^* =
   \text{argmin}_{\scr{D}} L(\scr{D}; \scr{C}, \scr{F}). \]
</p>
</div>
</div>
<div id="outline-container-org4d49109" class="outline-3">
<h3 id="org4d49109"><span class="section-number-3">1.3</span> Issues</h3>
<div class="outline-text-3" id="text-1-3">
<p>
At the design stage, the data generation distributions \(\scr{F}\) are often
simplified in order to reduce the amount of computation work for constructing
\(\scr{D}\), or even to ensure that a valid design \(\scr{D}\) exists. For
example, it is common to assume that the variance of the treatment effect
size is known or the data are missing completely at random if there is
missingness. Nevertheless, the consequences when these assumptions about
\(\scr{F}\) are inaccurate are largely ignored in practice. In our opinion,
this is one of the major causes for study failures in clinical trials.
</p>
</div>
</div>
<div id="outline-container-org692516d" class="outline-3">
<h3 id="org692516d"><span class="section-number-3">1.4</span> Goal</h3>
<div class="outline-text-3" id="text-1-4">
<p>
In this paper, we conduct simulation studies to evaluate the impact of the
misspecification of data generation distributions at the design stage. We
evaluate different study designs in the biomarker-efficacy study settings. We
also propose a general strategy for incorporating the uncertainties in the data
generation distributions to improve the robustness of candidate study
designs.
</p>
</div>
</div>
</div>
<div id="outline-container-org9f202f3" class="outline-2">
<h2 id="org9f202f3"><span class="section-number-2">2</span> A Motivation Example</h2>
<div class="outline-text-2" id="text-2">
<p>
Consider a single stage study. At the design stage, in order to specify
\(\scr{F}\), we assume that
</p>

<ul class="org-ul">
<li>\(\pi_1 = \pi^*\)</li>
<li>\(Y_i|T_i=t, A_i=j \sim N(\mu_{t,j}, \sigma^{2})\) for \(j=1,2\).</li>
</ul>

<p>
For the constraints \(\scr{C}\), we consider the family-wise error rate \(\alpha\)
under the global null hypothesis \(H_0: \delta_1 = \delta_2 = 0\) and the power
constraint such that the minimum individual power is at least \(\beta\). 
</p>

<p>
We consider several sets of actions \(\scr{A}\) for the family-wise type I error
rate control:
</p>
<ul class="org-ul">
<li>We apply Bonferroni adjustment by equally splitting \(\alpha\) among
hypotheses \(H_{0,j}\) (\(j=0,1,C\)).</li>
<li>We apply Bonferroni adjustment by splitting \(\alpha\) arbitrarily among
hypotheses \(H_{0,j}\) such that \(\alpha_{1} + \alpha_{2} + \alpha_{C} =
    \alpha\).</li>
</ul>

<p>
We then power the study with sample size \(N\) for the power constraints. 
</p>

<p>
Let \(L\) be the sample size. Then the optimal design \(\scr{D}^*\) will be the
valid design that gives the smallest sample size.
</p>

<p>
Next, we will evaluate the robustness of \(\scr{D}^*\) when \(\scr{F}\) is
misspecified. Specifically, we assume that in the true distribution
\(\scr{F}'\), \[ \pi_1 \sim Unif(\pi^* - \Delta, \pi^* + \Delta). \]
</p>

<p>
As metrics of robustness, we consider bias, mean squared error and standard
deviation of \(\delta_j\) as well as the power of the three hypothesis. We
report the worst case and the average case of these metrics with respect to
\(\scr{F}'\).
</p>
</div>
</div>
<div id="outline-container-orge833e7c" class="outline-2">
<h2 id="orge833e7c"><span class="section-number-2">3</span> Software</h2>
<div class="outline-text-2" id="text-3">
<p>
An online web application for this example is available at
<a href="https://olssol2.shinyapps.io/stress/">https://olssol2.shinyapps.io/stress/</a>.
</p>
</div>
</div>
<div id="outline-container-org58355c5" class="outline-2">
<h2 id="org58355c5"><span class="section-number-2">4</span> Team</h2>
<div class="outline-text-2" id="text-4">
<ul class="org-ul">
<li>Michael Rosenblum <i>michael.a.rosenblum@gmail.com</i></li>
<li>Chenguang Wang <i>cwang68@jhmi.edu</i></li>
<li>Yuchen Yang <i>yyang112@jhu.edu</i></li>
</ul>
</div>
</div>
</div>
</body>
</html>
